Sale!

TCAP Gene Cardiomyopathy dilated type 1N Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TCAP Gene Cardiomyopathy Dilated Type 1N Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TCAP gene, which are implicated in the development of Dilated Cardiomyopathy (DCM) type 1N. This condition is a form of heart disease that affects the heart’s ability to pump blood efficiently, leading to enlargement of the heart’s chambers and impaired cardiac function.

Given the genetic basis of DCM type 1N, identifying mutations in the TCAP gene can be crucial for early diagnosis, enabling timely management and intervention strategies for affected individuals. The test is particularly relevant for patients exhibiting symptoms of DCM or those with a family history of the condition, as it can provide essential insights into the genetic underpinnings of their cardiac issues.

Priced at 4400 AED, the test involves analyzing the patient’s DNA to detect any genetic alterations in the TCAP gene that may predispose them to this specific type of cardiomyopathy. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test represents a critical step towards personalized medicine in the field of cardiology, offering patients targeted and effective treatment plans based on their genetic makeup.

Description

TCAP Gene Cardiomyopathy dilated type 1N Genetic Test

Test Name: TCAP Gene Cardiomyopathy dilated type 1N Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TCAP Gene Cardiomyopathy, dilated type 1N NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TCAP Gene Cardiomyopathy, dilated type 1N NGS Genetic DNA Test gene TCAP

Test Details: TCAP gene cardiomyopathy, dilated type 1N is a genetic disorder that affects the heart muscle, leading to the development of dilated cardiomyopathy. This condition is caused by mutations in the TCAP gene, which provides instructions for producing a protein called telethonin. Telethonin is found in the heart muscle and plays a role in maintaining the structure and function of the heart. Individuals with TCAP gene cardiomyopathy, dilated type 1N may experience symptoms such as fatigue, shortness of breath, chest pain, and irregular heartbeats. Over time, the heart muscle becomes weakened and enlarged, leading to a decrease in its ability to pump blood efficiently.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can be used to detect mutations in the TCAP gene. This test involves analyzing the individual’s DNA to identify any genetic changes that may be causing the cardiomyopathy. NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for diagnosing genetic disorders. Genetic testing for TCAP gene cardiomyopathy, dilated type 1N can help confirm the diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations. It can also help identify other family members who may be at risk of developing the disorder. It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and guidance.

Test Name	TCAP Gene Cardiomyopathy dilated type 1N Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TCAP Gene Cardiomyopathy, dilated type 1N NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TCAP Gene Cardiomyopathy, dilated type 1N NGS Genetic DNA Test gene TCAP
Test Details	TCAP gene cardiomyopathy, dilated type 1N is a genetic disorder that affects the heart muscle, leading to the development of dilated cardiomyopathy. This condition is caused by mutations in the TCAP gene, which provides instructions for producing a protein called telethonin. Telethonin is found in the heart muscle and plays a role in maintaining the structure and function of the heart. Individuals with TCAP gene cardiomyopathy, dilated type 1N may experience symptoms such as fatigue, shortness of breath, chest pain, and irregular heartbeats. Over time, the heart muscle becomes weakened and enlarged, leading to a decrease in its ability to pump blood efficiently. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can be used to detect mutations in the TCAP gene. This test involves analyzing the individual’s DNA to identify any genetic changes that may be causing the cardiomyopathy. NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for diagnosing genetic disorders. Genetic testing for TCAP gene cardiomyopathy, dilated type 1N can help confirm the diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations. It can also help identify other family members who may be at risk of developing the disorder. It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and guidance.